CLOV vs. SKLZ, ALHC, ALLO, LRMR, TVTX, ALEC, CELC, AVAH, OCS, and CYH
Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Skillz (SKLZ), Alignment Healthcare (ALHC), Allogene Therapeutics (ALLO), Larimar Therapeutics (LRMR), Travere Therapeutics (TVTX), Alector (ALEC), Celcuity (CELC), Aveanna Healthcare (AVAH), Oculis (OCS), and Community Health Systems (CYH).
Skillz (NYSE:SKLZ) and Clover Health Investments (NASDAQ:CLOV) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk.
In the previous week, Skillz had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 2 mentions for Skillz and 1 mentions for Clover Health Investments. Skillz's average media sentiment score of 0.55 beat Clover Health Investments' score of 0.06 indicating that Clover Health Investments is being referred to more favorably in the news media.
Clover Health Investments has a net margin of -8.63% compared to Clover Health Investments' net margin of -78.69%. Skillz's return on equity of -48.07% beat Clover Health Investments' return on equity.
Skillz has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Skillz, indicating that it is currently the more affordable of the two stocks.
Skillz received 15 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 55.38% of users gave Skillz an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Skillz currently has a consensus target price of $11.50, indicating a potential upside of 80.53%. Clover Health Investments has a consensus target price of $1.50, indicating a potential upside of 68.54%. Given Clover Health Investments' stronger consensus rating and higher possible upside, research analysts plainly believe Skillz is more favorable than Clover Health Investments.
Skillz has a beta of 2.76, suggesting that its stock price is 176% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500.
19.4% of Skillz shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 22.7% of Skillz shares are held by company insiders. Comparatively, 21.8% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Skillz beats Clover Health Investments on 11 of the 18 factors compared between the two stocks.
Get Clover Health Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clover Health Investments Competitors List
Related Companies and Tools
